Results 151 to 160 of about 745,289 (215)

Identification of antibody-drug conjugate payloads that are substrates of ATP-binding cassette drug efflux transporters. [PDF]

Cancer Drug Resist
Roth JS, Guo H, Chen L, Shen M, Gbadegesin O, Robey RW, Gottesman MM, Hall MD.   +7 more
europepmc   +1 more source

Mechanisms of resistance to antibody-drug conjugates in cancer therapy: molecular basis and therapeutic strategies. [PDF]

Cancer Drug Resist
Hao Y, Song Z.
europepmc   +1 more source

Formulation Matters: The Overlooked Engine of Stability and Success in Antibody-Drug Conjugates. [PDF]

Pharmaceuticals (Basel)
Torres-Dias L, Moore E, Shukla S, Dash AK.   +3 more
europepmc   +1 more source

Mislocalisation of FLT3-ITD receptor contributes to MV4-11 leukaemia cell resistance to antibody-drug conjugate. [PDF]

J Enzyme Inhib Med Chem
Nirachonkul W, Farrell MP, Tolbert TJ, Okonogi S, Tima S, Anuchapreeda S, Chiampanichayakul S, Siahaan TJ.   +7 more
europepmc   +1 more source

Antibody-Drug Conjugates and Beyond: Next-Generation Targeted Therapies for Breast Cancer. [PDF]

Cancers (Basel)
Wali AF, El-Tanani M, Talath S, Rabbani SA, Rangraze IR, Satyam SM, Avagimyan A, Hoffmann K, Ilias I, Ispas S, Viviana M, Paczkowska A, Rizzo M.   +12 more
europepmc   +1 more source

A review of targeted drug delivery with antibody-drug complexes. [PDF]

J Pharmacol Exp Ther
Sanjanwala D, Meng Y, Guo Z, Bordeau B.
europepmc   +1 more source

Rational payload selection enables high antitumoral efficacy of an anti-EGFR antibody-drug conjugate against ovarian tumors. [PDF]

Neoplasia
Almaraz-Postigo S, Redondo-Puente M, Pandiella A.   +2 more
europepmc   +1 more source

A dialogue on innovation in anticancer drug discovery. [PDF]

RSC Med Chem
Samajdar S.
europepmc   +1 more source